Chlorogenic acid enhances glucose metabolism and antioxidant system in high-fat diet and streptozotocin-induced diabetic mice

Journal of the Korean Society of Food Science and Nutrition

Volumn 41, Issue 6, 2012, Pages 774-781

  Lee, Jin ^a   Seo, Kwon Il ^a   Kim, Myung Joo ^b   Lee, Su Jin ^b   Park, Eun Mi ^c   Lee, Mi Kyung ^a  

^a Sunchon National University   (South Korea)

^b Suseong College   (South Korea)

^c Division of Bio Applied Science Sung Duck C University   (South Korea)

Author keywords

Antioxidant system; Chlorogenic acid; Diabetes; Glucose metabolism; High fat diet

Indexed keywords

EID: 84922687090     PISSN: 12263311     EISSN: None     Source Type: Journal    
DOI: 10.3746/jkfn.2012.41.6.774     Document Type: Article

References (52)

1. Rhee SY, Kim YS, Oh S, Choi WH, Park JE, Jeong WJ. 2005. Diabcare Asia 2001-Korea country report on outcome data and analysis. Korean J Intern Med 20: 48-54.
2. Schwarz PE. 2005. Report from the congress of the American Diabetes Association (ADA). Exp Clin Endocrinol Diabetes 113: 475-479.
3. Ministry of Health and Welfare. 2010. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Surveys (KNHANES V-1). Ministry of Health and Welfare, Korea.
4. Sakurai T, Tsuchiya S. 1988. Superoxide production from nonenzymatically glycated protein. FEBS Lett 236: 406-410.
5. Cosio FG, Kudva Y, Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. 2005. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67: 2415-2421.
6. Jay D, Hitomi H, Griending KK. 2006. Oxidative stress and diabetic cardiovascular complications. Free Radical Biol Med 40: 183-192.
7. Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
8. Rice-Evans CA, Miller NJ, Paganga G. 1996. Structure an-tioxidant activity relationship of flavonoids and phenolic acids. Free Radical Biol Med 20: 933-956.
9. Chen JH, Ho CT. 1997. Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds. J Agric Food Chem 45: 2374-2378.
10. Nicasio P, Aguilar-Santamaria L, Aranda E, Ortiz S, Gonzalez M. 2005. Hypoglycemic effect and chlorogenic acid content in two Cecropia species. Phytother Res 19: 661-664.
11. Rodriguez de Sotillo DV, Hadley M. 2000. Chlorogenic acid modifies plasma and liver concentrations of cholesterol, tri-acylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 13: 717-726.
12. Rodriguez de Sotillo DV, Hadley M, Sotillo JE. 2006. Insulin receptor exon 11+/- is expressed in zucker (fa/fa) rats and chlorogenic acid modifies their plasma insulin and liver protein and DNA. J Nutr Biochem 17: 63-71.
13. Bassoli BK, Cassola P, Borba-Murad GR, Constantin J, Salgueiro-Pagadigorria CL, Bazotte RB, da Silva RS, de Souza HM. 2008. Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochem Funct 26: 320-328.
14. Thom E. 2007. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J Int Med Res 35: 900-908.
15. Li BH, Ma XF, Wu XD, Tian WX. 2006. Inhibitory activity of chlorogenic acid on enzymes involved in the fatty acid synthesis in animals and bacteria. IUBMB Life 58: 39-46.
16. Cho AS, Jeon SM, Kim MJ, Yeo JY, Seo KI, Choi MS, Lee MK. 2010. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 48:937-943.
17. Reed MJ, Scribner KA. 1999. In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery. Diabetes Obes Metab 1:75-86.
18. Lv L, Wu SY, Wang GF, Zhang JJ, Pang JX, Liu ZQ, Xu W, Wu SG, Rao JJ. 2010. Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Phytother Res 24: 219-224.
19. American Institute of Nutrition. 1977. Report of the American Institute of Nutrition ad hoc Committee of Standard for Nutritional Studies. J Nutr 107: 1340-1348.
20. McCord JM, Fridovich I. 1969. Superoxide dismutase: an enzymetic function for erythrocuprein (Hemocuprein). J Biol Chem 244: 2049-6055.
21. Hulcher FH, Oleson WH. 1973. Simplified spectrophoto-metric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 14: 625-631.
22. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
23. Davidson AL, Arion WJ. 1987. Factors underlying significant underestimation of glucokinase activity in crude liver extract: physiological implications of higher cellular activity. Arch Biochem Biophys 253: 156-167.
24. Newgard CB, Hirsch LJ, Foster DW, McGarry DJ. 1983. Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. J Biol Chem 258: 8046-8052.
25. Alegre M, Ciudad CJ, Fillat C, Guinovart JJ. 1988. Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal Biochem 173: 185-189.
26. Bentle LA, Lardy HA. 1976. Interaction of anions and divalent metal ions with phosphoenolpyruvate carboxykinase. J Biol Chem 251: 2916-2921.
27. Marklund S, Marklund G. 1974. Involvement of the super-oxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. EurJBiochem 47: 469-474.
28. Aebi H. 1988. Catalase in vitro. Methods Enzymol 105: 121-126.
29. Paglia ED, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med 70: 158-169.
30. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
31. Tarladgis BG, Pearson AM, Dugan LR. 1964. Chemistry of the 2-thiobarbituric acid test for determination of oxidative rancidity in foods. J Sci Food Agric 15: 602-607.
32. Mullarkey CJ, Edelstein D, Brownlee M. 1990. Free radical generation by glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939.
33. Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS. 2006. Antihyperglycemic and antioxidant properties of caffeic acid in db/dbmice. J Pharmacol Exp Ther 318: 476-483.
34. Karthikesan K, Pari L, Menon VP. 2010. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nico-tinamide-induced diabetic rats. Gen Physiol Biophys 29: 23-30.
35. Ong KW, Hsu A, Song L, Huang D, Tan BKH. 2011. Poly-phenols-rich Vernonia amygdalinashows anti-diabetic effects in streptozotocin-induced diabetic rats. E thnophar -macology 133: 598-607.
36. Mohamed-Ali V, Pinkney JH, Panahloo A, Goodrick S, Coppack SW, Yudkin JS. 1997. Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 14: 376-380.
37. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
38. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural network. Science 269: 546-549.
39. Lee JH, Kim SK, Hur KY, Choi HS, Jung JY, Shim WS, Lee HJ, Ahn CW, Lim SK, Kim KR, Lee HC, Cha BS. 2003. Efficacy of serum leptin level as an indicator to predict the clinical response of rosiglitazone in patients with type 2 diabetes mellitus. Diabetes Metab J 27: 420-432.
40. Kim DJ, Jeong YJ, Kwon JH, Moon KD, Kim HJ, Jeon SM, Lee MK, Park YB, Choi MS. 2008. Beneficial effect of chungkukjang on regulating blood glucose and pancreatic β-cell functions in C75BL/KsJ-db/dbmice. J Med Food 11: 215-223.
41. Munoz MC, Barbera A, Dominguez J, Fermandez-Alvarez J, Gomis R, Guinovart JJ. 2001. Effects of tungstate, a new potential oral antidiabetic agents in Zucker diabetic fatty rats. Diabetes 50: 131-139.
42. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM. 1999. Dual roles for glucokinase in glucose ho-meostasis as determined by liver and pancreatic β-cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315.
43. Iynedjian PB, Gjinovei A, Renold AE. 1988. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. J Biol Chem 263: 740-744.
44. DeFronzo RA, Bonadonna RC, Ferrannini E. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368.
45. Hemmerle H, Burger HJ, Below P, Schubert G, Rippel R, Schindler PW, Paulus E, Herling AW. 1997. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J Med C hem 40: 137-145.
46. Parker JC, Vanvolkenburg MA, Levy CB, Martin WH, Burk SH, Kwon Y, Giragossian C, Grant TG, Carpino PA, Mc-Pherson RK, Vestergoard P, Treadway JL. 1998. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. Diabetes 47: 1630-1636.
47. Herling AW, Schwab D, Burger HJ, Maas J, Hammerl R, Schmidt D, Strohschein S, Hemmerle H, Schubert G, Petry S, Kramer W. 2002. Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR(-)) by the glucose-6-phos-phate translocase inhibitors 3025. Biochem Biophys Acta 1569: 105-110.
48. Wolff SP, Jiang ZY, Hunt JV. 1991. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radical Biol Med 10: 339-352.
49. MeLennan SV, Hefferman S, Wright L. 1991. Changes in hepatic glutathione metabolism in diabetes. Diabetes 40: 344-348.
50. Deisseroth A, Dounce AL. 1970. Catalase: physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 50: 319-375.
51. Ceriello A. 1999. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the patho-genesis of diabetic complications. Diabetes Nutr Metab 12: 42-46.
52. Kim TH, Kim SS, Hong YS, Shin MS, Chung YR, Kang JY. 2005. The effects of 12 weeks exercise program on su-peroxide dismutase and malondialdehyde of non-insulin dependent diabetes mellitus (NIDDM) patients. JCD 7: 217-224.